Prelude Therapeutics (PRLD) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Prelude Therapeutics

    NASDAQ: PRLD · Real-Time Price · USD
    1.23
    0.04 (3.36%)
    At close: Sep 11, 2025, 3:59 PM
    1.21
    -1.63%
    After-hours: Sep 11, 2025, 04:10 PM EDT

    Prelude Therapeutics Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 12.47M 25.29M 30.61M 31.83M
    Short-Term Investments
    		 121.14M 207.64M 171.12M 259.4M
    Long-Term Investments
    		 n/a n/a 4.04M 4.04M
    Other Long-Term Assets
    		 4.15M 4.34M 5.38M 303K
    Receivables
    		 n/a n/a n/a n/a
    Inventory
    		 n/a n/a n/a n/a
    Other Current Assets
    		 2.28M 2.65M 2.65M 3.88M
    Total Current Assets
    		 135.9M 235.59M 204.38M 295.12M
    Property-Plant & Equipment
    		 35.47M 37.74M 6.7M 5.64M
    Goodwill & Intangibles
    		 n/a n/a n/a n/a
    Total Long-Term Assets
    		 39.62M 42.08M 16.12M 9.98M
    Total Assets
    		 175.51M 277.67M 220.5M 305.1M
    Account Payables
    		 7.73M 4.58M 6.78M 7.84M
    Deferred Revenue
    		 n/a n/a n/a n/a
    Short-Term Debt
    		 2.7M n/a 1.83M 1.74M
    Other Current Liabilities
    		 7.09M 6.61M 5.58M 3.27M
    Total Current Liabilities
    		 25.64M 21.83M 21.7M 19.2M
    Long-Term Debt
    		 n/a n/a n/a n/a
    Other Long-Term Liabilities
    		 3.09M 3.34M 3.36M n/a
    Total Long-Term Liabilities
    		 18.41M 18.75M 3.36M n/a
    Total Liabilities
    		 44.06M 40.58M 25.06M 19.2M
    Total Debt
    		 18.02M 16.89M 1.83M 1.74M
    Common Stock
    		 4K 5K 5K 5K
    Retained Earnings
    		 -583.56M -456.39M -334.56M -219.12M
    Comprehensive Income
    		 35K 223K -1.69M -711K
    Shareholders Equity
    		 131.46M 237.09M 195.44M 285.9M
    Total Investments
    		 121.14M 207.64M 171.12M 259.4M

    Add to Watchlist